IMPORTANT NOTE: The following information is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that use of the drug is safe, appropriate or effective for you. Consult your healthcare professional before using this drug.
Pronounced: (me-SAL-a-meen/a-MEE-noe-sal-i-SIL-ik AS-id)
Pentasa Oral Uses
Mesalamine (also known as 5-aminosalicylic acid) is used to lessen the signs and severity of ulcerative colitis (remission). It does not cure ulcerative colitis (a bowel disease), but mesalamine may decrease symptoms such as stomach pain, diarrhea, and rectal bleeding caused by irritation/swelling of the colon/rectum. Mesalamine is an aminosalicylate anti-inflammatory drug. It is believed to work by blocking the production of certain natural chemicals that may cause pain and swelling. After an attack has been treated, mesalamine is used to increase the amount of time between attacks of ulcerative colitis.
How To Use Pentasa Oral
Take this medication by mouth with or without food, usually once daily in the morning or as directed by your doctor.
Swallow the capsules whole. Do not chew or crush the capsules. Do not take with antacids. Doing so can interfere with release of the drug into the colon.
Dosage is based on your medical condition and response to therapy.
Use this medication regularly to get the most benefit from it. To help you remember, take it at the same time each day.
Tell your doctor if your condition persists or worsens.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.
Information last revised May 2010 Copyright(c) 2010 First DataBank, Inc.